Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 26 January 2009, doi:10.1136/bmj.a3172
Cite this as: BMJ 2009;338:a3172
Steven G Deeks, professor of medicine1, Andrew N Phillips, professor of epidemiology2
1 Positive Health Program, San Francisco General Hospital, University of California, San Francisco, CA 94131, USA , 2 HIV Epidemiology and Biostatistics Group, Department of Primary Care and Population Sciences, and Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, University College London, London NW3 2PF
Correspondence to: S G Deeks, 995 Potero Avenue, San Francisco, CA 94110, USA sdeeks@php.ucsf.edu
| The first 150 words of the full text of this article appear below. |
|
More than 25 antiretroviral drugs from six therapeutic classes are now available for the management of HIV infection (box 1). Most patients who take medication achieve durable and perhaps lifelong viral
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses